 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning BAC B.V. (Biotechnology Application Centre B.V.)
|
-
BAC and LFB Biotechnologies to Develop Custom Ligand for Purifying Recombinant Factor VIIa
(30 May 2008)
BAC BV, the Bio Affinity Company, announced that it has entered into a collaboration with LFB Biotechnologies, a wholly owned subsidiary of LFB S.A., a biopharmaceutical company working in the highly specialized field of plasma-derived medicinal and ...
-
BAC signs license agreement with Hematech
(26 Mar 2008)
BAC BV announced that it has entered into a license and supply agreement with Hematech, Inc., a subsidiary of Kirin Pharma that specialises in the production of human antibodies in transgenic cows. The license covers the use of a custom designed ...
-
BAC and Octapharma to develop custom ligand for recombinant plasma protein
(18 Mar 2008)
BAC BV announced that it has entered into a collaboration with Octapharma AG. The objective of the collaboration is to discover and develop a custom CaptureSelect(r) ligand for the purification of a recombinant Factor IX product, developed by ...
-
BAC appoints Dr Andrew Carr as Chairman of Supervisory Board
(30 Jan 2008)
BAC BV, the Bio Affinity Company, announced the appointment of Dr Andrew Carr as Chairman to its Supervisory Board.Dr Carr brings a wealth of experience in the biotech industry to the role. As CEO of Amersham Biosciences and a Director of Amersham ...
-
GE Healthcare and BAC start collaboration in biopharmaceutical purification
(24 Oct 2006)
GE Healthcare and BAC BV announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area. Under the terms of the agreement, the two companies plant to develop new affinity chromatography media ...
Additional information
BAC B.V. (Biotechnology Application Centre B.V.)
Naarden, Netherlands
Company
|
|
|
|
|
|
Top
